by Commetric | Mar 8, 2021
Earnings announcements are one of the most popular channels for financial communications. However, the media resonance of such announcements is decreasing due to shrinking editorial staff and budgets, and most top-tier publications like the New York Times or the Wall...
by Commetric | Feb 18, 2021
Our recent pharma analysis concluded that journalists have started to report more favourably of pharma’s work and that companies are experiencing a reputational boost as the pandemic highlights their role in developing medications and vaccines. This comes at a time...
by Commetric | Feb 9, 2021
Historically more used to marketing their specific products than their own names, pharma companies are now starting to launch additional corporate branding efforts and reexamine their marketing and communications. As the industry’s role in fighting COVID-19...
by Commetric | Feb 5, 2021
Not long ago, when a pharma company made headlines in the mainstream media, it was usually for all the wrong reasons – from the opioid crisis to high drug prices. We were so used to seeing the media demonise Big Pharma that it became common to...
by Commetric | Feb 2, 2021
In the past few years, the pharmaceutical industry has been experiencing unprecedented reputational declines, mainly because of some companies’ association with the opioid crisis and high drug prices. As the media conversation around the ongoing...